eLaws | eCases | United States Code | Federal Courts |
Home » Rulemaking » Draft Guidance for Industry on Attachment to Guidance on Antiviral Product Development: Submitting Hepatitis C Virus Resistance Data; Availability

Draft Guidance for Industry on Attachment to Guidance on Antiviral Product Development: Submitting Hepatitis C Virus Resistance Data; Availability

Document ID: FDA-2005-D-0282-0006
Document Type: Notice
Agency: Food And Drug Administration
Topics: No Topics associated with this document
Federal Register Number: 2013-04196
View Document:  View as format pdf View as format html

Details Information

Document Subtype: Notice of Availability
Received Date: February 25 2013, at 12:00 AM Eastern Standard Time
Start-End Page: 12759 - 12760
Page Count: 2
Comment Start Date: February 25 2013, at 12:00 AM Eastern Standard Time
Comment Due Date: April 26 2013, at 11:59 PM Eastern Standard Time

Comments

   
Total: 2
GlaxoSmithKline - Comment
Posted: 04/26/2013     ID: FDA-2005-D-0282-0008

Apr 26,2013 11:59 PM ET
Boehringer Ingelheim Pharmaceuticals, Inc - Comment
Posted: 04/26/2013     ID: FDA-2005-D-0282-0009

Apr 26,2013 11:59 PM ET

Related Documents

Total: 0
No documents available.